Center For Biomolecular Studies - CA Alameda, Fremont 94536

Center For Biomolecular Studies entered the industry of Medical Research in 1988 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Caroline Ritz-Gold by calling (510) 791-5185 during business hours. You can also write to the business’ Single Location at 38451 Timpanogas Circle, Fremont, California CA 94536. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Center For Biomolecular Studies
Representative: Caroline Ritz-Gold
Place of Business: 38451 Timpanogas Circle, Fremont, CA 94536
Contact Number: (510) 791-5185
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 541720
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1988
Income/Year: $50.000 to $99.999
Laborers: 1 to 4
Share This Company:

Center For Biomolecular Studies is a company operating from Alameda, California providing professional Medical Research and relevant B2B variables. It was founded in 1988 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.

With a current employee count of 1 to 4, Center For Biomolecular Studies has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Caroline Ritz-Gold at (510) 791-5185 for related queries, or to locate its Single Location using the coordinates 37.57552,-121.964389.

The Single Location can also be found at the street address 38451 Timpanogas Circle in Fremont, California 94536 and can be engaged online through the company website at , the company Twitter , and Facebook page .